NEXGEL, INC.(NXGL)— Stock Profile, AI Score & Financials
Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .
NEXGEL, INC. (NXGL) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores NXGL at 34.1/100 on a 32-signal composite quality model, placing it at rank #2,361 of 2,962 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), NEXGEL, INC. reports quarterly revenue of $3.7M, net income of $-3.6M. Top institutional holders of NXGL by reported 13-F value include SUSQUEHANNA INTERNATIONAL GROUP, LLP, Virtu Financial, GEODE CAPITAL MANAGEMENT, based on the most recent SEC filings. NXGL trades on the Nasdaq exchange and files with the SEC under CIK 1468929. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NXGL daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for NEXGEL, INC. directly from SEC EDGAR.
AI Quality Score
34.1/100
AI Rank
#2,361
Revenue
$3.7M
Net Income
$-3.6M
NXGL key financials by period
NEXGEL, INC. reported revenue, net income and margins by fiscal period, from SEC filings.
Period
Form
Revenue
Net income
Operating margin
FY 2025
10-K
$11.4M
$-3.0M
-29.3%
FY 2024
10-K
$8.7M
$-3.3M
-40.9%
FY 2023
10-K
$4.1M
$-3.2M
-85.0%
FY 2022
10-K
$2.0M
$-4.7M
-163.5%
FY 2021
10-K
$1.6M
$-4.3M
-165.7%
FY 2020
10-K
$674.0K
$-2.3M
—
Institutions holding NXGL
Institutional investors reporting a position in NEXGEL, INC. on SEC Form 13F.
